JPJulia Stela Xavier Paim

Julia Stela Xavier Paim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Stela Xavier Paim has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Impact of the SARS-CoV-2 Pandemic on Bone Marrow Transplants in Brazil

    by Sacha Krolow e Silva, Jéssica Manami Seki, Helena Angelica Blume, Matheus Vinícius Henrique, Marcela Silva Fructos, Maria Eduarda Meirelles Marchese, Júlia de Azambuja Vaniel, Thais Matos Silva, Ketlin Laufer Schuh, Luanna Carla Brandão Pereira, et al.

    Introduction: Bone marrow transplantation (BMT) is an established therapy for the treatment of various health conditions. In Brazil, procedures are registered by the Brazilian Association of Organ Transplants (ABTO) and the Hospital Information System of the National Health System (SIH/SUS). The COVID-19 pandemic has forced health systems to adapt to the increased risk of death. Objectives: To evaluate the landscape of BMT in Brazil from 2018 to 2024, comparing the pre-pandemic, pandemic, and post-pandemic periods in terms of frequency, type of transplant, registration, and regional distribution. Methods: A retrospective descriptive study using data on BMTs performed from January 2018 to June 2024, from the databases of the SIH/SUS and the ABTO, which were subsequently analyzed in an R environment. Results: A total of 21,164 BMTs were recorded by ABTO (61% autologous) and 5,841 by SIH/SUS (predominantly allogeneic). A reduction in procedures was observed during the pandemic, followed by a recovery in the post-pandemic period in both databases (ABTO: +32.6% vs. pandemic period; SIH/SUS: +29.1%). ABTO maintained a predominance of autologous transplants (≈ 58-61%), while SIH/SUS showed a consistent predominance of allogeneic transplants (≈ 73-75%), mainly from related donors. There was a strong regional concentration in the Southeast, especially in São Paulo, followed by the South, Northeast, Midwest, and North. The analyses did not show statistically significant differences between regions but showed a post-pandemic growth trend. Regional heterogeneity was observed in terms of the type of transplant and marked inequality in the distribution of transplant centers, with a worse center/patient ratio in the North and Midwest regions. Despite the numerical differences, the databases showed convergent temporal and regional patterns. Conclusion: From 2018 to 2024, BMT procedures in Brazil were significantly impacted by the pandemic, with subsequent recovery in both databases. The findings highlight structural inequalities in access to transplantation and reinforce the need for greater integration and standardization of information systems, as well as the expansion of infrastructure in less-served regions.

  • Open Access

    O Impacto da Pandemia do Vírus SARS-CoV-2 nos Transplantes de Medula Óssea no Brasil

    by Sacha Krolow e Silva, Jéssica Manami Seki, Helena Angelica Blume, Matheus Vinícius Henrique, Marcela Silva Fructos, Maria Eduarda Meirelles Marchese, Júlia de Azambuja Vaniel, Thais Matos Silva, Ketlin Laufer Schuh, Luanna Carla Brandão Pereira, et al.

    Introdução: O transplante de medula óssea (TMO) é uma terapia consolidada para o tratamento de diversas condições de saúde. No Brasil, os procedimentos são registrados pela Associação Brasileira de Transplantes de Órgãos (ABTO) e pelo Sistema de Informações Hospitalares do Sistema Único de Saúde (SIH/SUS). A pandemia por COVID-19 fez com que os sistemas de saúde tivessem que se adaptar ao aumento da incidência do risco de morte. Objetivos: Avaliar o panorama dos TMO no Brasil no período de 2018 a 2024, comparando os períodos pré-pandêmico, pandêmico e pós-pandêmico quanto à frequência, tipo de transplante, registro e distribuição regional. Métodos: Estudo descritivo retrospectivo que utilizou dados sobre os TMO realizados no período de janeiro de 2018 a junho de 2024 a partir das bases de dados do SIH/SUS e da ABTO, que foram posteriormente analisados em ambiente R. Resultados: Foram registrados 21.164 TMO pela ABTO (61% autólogos) e 5.841 pelo SIH/SUS (predomínio de alogênicos). Observou-se redução dos procedimentos durante a pandemia, seguida de recuperação no período pós-pandêmico em ambas as bases (ABTO: +32,6% vs. período pandêmico; SIH/SUS: +29,1%). A ABTO manteve predominância de transplantes autólogos (≈ 58-61%), enquanto o SIH/SUS apresentou predomínio consistente de alogênicos (≈ 73-75%), principalmente de doadores aparentados. Houve forte concentração regional no Sudeste, especialmente em São Paulo, seguida pelas Regiões Sul, Nordeste, Centro-Oeste e Norte. As análises não demonstraram diferenças estatisticamente significativas entre Regiões, mas evidenciaram tendência de crescimento pós-pandêmico. Observaram-se heterogeneidade regional quanto ao tipo de transplante e marcada desigualdade na distribuição de centros transplantadores, com pior relação centro/paciente nas Regiões Norte e Centro-Oeste. Apesar das diferenças numéricas, as bases apresentaram padrões temporais e regionais convergentes. Conclusão: No período de 2018 a 2024, os procedimentos de TMO no Brasil sofreram impacto significativo da pandemia, com posterior recuperação em ambas as bases. Os achados evidenciam desigualdades estruturais no acesso ao transplante e reforçam a necessidade de maior integração e padronização dos sistemas de informação, além da expansão da infraestrutura em Regiões menos assistidas.

  • Open Access

    Insights of pediatric bone marrow transplantation in Brazil - A registry-based study (2018–2024)

    by Sacha Krolow e Silva, Julia Stela Xavier Paim, Jéssica Manami Seki, Júlia Beck Stüker, Liliane Ghi Mei Law, Luize Paz Bortolon, Sally Noemi Caballero Coronel, Manoela Silveira Gonçalves, Isabelly Rodrigues de Souza, Stefany da Costa Rezena Pinto, et al.

    Background: Hematopoietic cell transplantation (HCT) is established as a curative strategy for several severe pediatric hematological and immunological disorders. However, despite Brazil’s extensive public transplant infrastructure, national data on pediatric HCT trends remain insufficiently characterized. Objective: To analyze temporal trends, regional distribution, and modality characteristics of pediatric HCT in Brazil from 2018 to 2024, including the impact of the COVID-19 pandemic. Methods: This retrospective descriptive study used data from the Brazilian Transplant Registry (RBT/ABTO). Descriptive statistics were used and transplant modalities were compared across pre-pandemic (2018–2019), pandemic (2020–2022), and post-pandemic (2023–2024) periods using Pearson’s chi-square test. Results: A total of 3,592 pediatric BMT procedures were reported. Allogeneic transplantation predominated throughout the study period (68.3%–87.5%), while the proportion of autologous procedures increased significantly during the pandemic (p < 0.001). S.o Paulo concentrated more than half of all procedures, indicating substantial regional concentration. The lowest annual volume occurred in 2024 (n = 377), potentially reflecting incomplete or revised registry data. Conclusion: The data showed temporal variations, pandemic associated changes in transplantation modalities, and persistent regional disparities. These findings highlight the complexity of pediatric transplant care in Brazil and the need for standardized data collection and policies to reduce access inequities.